Hangzhou Tigermed Consulting (HKG:3347, SHE:300347) reported 413.2 million yuan in loss attributable to owners for the first half, compared with an attributable profit of 383.3 million yuan a year ago, a Friday bourse filing showed.
Loss per share for the period was 0.48 yuan, whereas the company had made earnings per share of 0.45 yuan in the prior-year period.
For the six months ended June 30, operating revenue was 3.71 billion yuan, versus 3.25 billion yuan previously, the Chinese medical laboratory operator said.